Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
A prospective, large, pragmatic, randomized trial to study the impact of METFORMIN and
healthy lifestyle intervention (LIFE) vs. LIFE alone on patient-centered outcomes of body
weight, SGA-adherence and satisfaction, psychiatric symptom burden (e.g. mood/anxiety), and
Quality of Life.